Logout Login Cart iconShop
Contact Sales

Search

Filters

Content Type

Products

Clear Filters

Search Results for "vbv card, 【 Visit Amsiga.com 】 ojM3t5p, cvv shop 2020, list of non vbv sites, savastan0 c VdDc"

Looking for quality documents?
publications icon
Protein A ELISA Kit for Native and Recombinant Protein A (9000-1)- Reagent D- Spanish
publications icon
Protein A ELISA Kit for Native and Recombinant Protein A (9000-1)- Reagent D- German
publications icon
Protein A ELISA Kit for Native and Recombinant Protein A (9000-1)- Reagent D- Swedish
publications icon
Protein A ELISA Kit for Native and Recombinant Protein A (9000-1)- Reagent D- Hebrew
news icon
Repligen Boasts about the Size of Its Column
event icon
Dynamic Dialysis: A Novel Method for Process Scale Membrane Separation
Learn how the SpectraFlo™ Dynamic Dialysis System accelerates membrane separation of fragile proteins, viscous fluids and polymer gels, such as hyaluronic acid. September 24, 2018 | 24 minutes
external link icon
Repligen Announces Pricing of $100 Million of 2.125% Convertible Senior Notes due 2021
WALTHAM, Mass., May 19, 2016 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN) (the “Company”) today announced the pricing of an underwritten public offering of $100 million aggregate principal amount of 2.125% Convertible Senior Notes due 2021 (the “Notes”). The Company has granted the underwriters a 30-day option to purchase up to an additional $15 million aggregate principal amount of Notes. The offering is expected to close on or about May 24, 2016, subject to customary closing conditions. Jefferies is acting as the sole book-running manager, and Janney Montgomery Scott and Craig-Hallum Capital Group are acting as co-managers in the offering.  Perella Weinberg Partners LP and J. Wood Capital Advisors LLC are serving as financial advisors to the Company in connection with the offering.
Interest on the Notes will be paid semiannually in arrears on June 1 and December 1 of each year at the rate of 2.125% per year, beginning on December 1, 2016. The Notes will
external link icon
Karen A. Dawes Elected as Repligen Co-chairperson of the Board of Directors
event icon
Configurability and Compliance for Automated TFF up to 500L
Driven by the rise in cell and gene therapies, TFF unit operations at scales from 10 mL to 500 L now require the single-use, automation and data integrity capabilities previously reserved for larger scale systems. The newly developed KrosFlo® KMPi TFF System from Repligen provides walk-away automation for concentration, diafiltration and fed-batch processes with TMP control, closed and single-use flow paths and 21 CFR Part 11 software compliance for processes up to 500L. Key components to this new system include: a patented automatic back-pressure control valve, a proprietary control board that enables plug-and-play hardware connectivity and modern software built upon a secure SQL database. Key technical features and applications supported by flexible configurations of the KrosFlo® KMPi TFF System will be discussed.
event icon
XCell™ Lab System for Simplified and Scaled-down Intensification
XCell ATF® technology can expand bioprocess facility capacity and throughput with cell densities up 300 x 106 VCD/mL. The newly launched XCell™ Lab Controller System accelerates development of robust intensified processes at volumes as low as 0.5L, reducing media costs per run and facilitating advancement to manufacturing. The benefits of key features such as a 0.5L single-use device, permeate pressure recording, a pump-based control logic loop, support for two devices per controller and a modern smartphone-like software interface are be discussed.
Close modal

A new look. A better way to explore Repligen.

We’ve redesigned Repligen.com to help you find the right solutions faster, with greater clarity and less effort.

Find what you need faster
Get to the right information with quicker site speed

Explore the site with ease
Navigate easily with an intuitive, simple site structure

Access product details instantly
Find products and resources faster, in fewer clicks

Get support when you need it
Connect with our team when you need support